Evid Invest
Who owns BBIOWhat BBIO owns — n/a

Who owns BridgeBio Pharma, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of BBIO from SEC Form 13F filings across 471 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 471 institutions disclosed 191.8M shares of BridgeBio Pharma, Inc. worth $12.66B — about 97.9% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.

471

13F holders

$12.66B

value, 2026 filers

97.9%

of shares outstanding (191.8M sh)

68

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BBIO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Janus Henderson Group Ltd.NEW14.6M$957.7M0.4%7.4%new
2FARALLON CAPITAL MANAGEMENT, L.L.C.14.2M$937.5M4.0%7.3%+32.6%
3BlackRock, Inc.10.4M$683.6M0.0%5.3%+1.0%
4VIKING GLOBAL INVESTORS LP9.8M$644.3M2.0%5%-1.6%
5WELLINGTON MANAGEMENT GROUP LLP9.5M$622.4M0.1%4.8%+78.2%
6Kohlberg Kravis Roberts & Co. L.P.8.3M$543.6M10.8%4.2%-37.7%
7VANGUARD CAPITAL MANAGEMENT LLC7.9M$520.7M0.0%4%+0.2%
8VANGUARD PORTFOLIO MANAGEMENT LLC7.5M$492.5M0.0%3.8%-2.2%
9STATE STREET CORP5.0M$327.5M0.0%2.5%+12.2%
10Invesco Ltd.4.3M$284.1M0.0%2.2%+16.6%
11JPMORGAN CHASE & CO4.0M$264.5M0.0%2%+66.8%
12TWO SIGMA INVESTMENTS, LP3.7M$240.8M0.2%1.9%-22.5%
13FRANKLIN TEMPLETON INC3.3M$255.4M0.1%1.7%+51.8%
14GEODE CAPITAL MANAGEMENT, LLC3.3M$215.8M0.0%1.7%-4.1%
15Aisling Capital Management LP3.1M$203.3M67.9%1.6%-32.7%
16ADAGE CAPITAL PARTNERS GP, L.L.C.3.0M$199.5M0.3%1.5%+34.6%
17UBS Group AG2.5M$166.0M0.0%1.3%+43.6%
18Paradigm Biocapital Advisors LPNEW2.3M$154.5M3.1%1.2%new
19D. E. Shaw & Co., Inc.2.2M$146.3M0.1%1.1%-38.8%
20Polar Capital Holdings Plc2.2M$141.5M0.3%1.1%+4.2%
21MANUFACTURERS LIFE INSURANCE COMPANY, THE2.0M$128.4M0.1%1%-0.3%
22SC US (TTGP), LTD.1.9M$122.4M0.5%0.9%0.0%
23PRICE T ROWE ASSOCIATES INC /MD/1.7M$114.8M0.0%0.9%+1.1%
24CITADEL ADVISORS LLC1.7M$113.5M0.0%0.9%-54.1%
25PRIMECAP MANAGEMENT CO/CA/1.7M$111.8M0.1%0.9%+67.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.